查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439256

血液净化设备 - 全球市场考量、竞争状况、市场预测 (2030)

Blood Purification Devices/Equipment/Methods - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球血液净化设备市场规模预计2023年将达到49亿美元，2030年将达到62.7亿美元，2024-2030年预测期间复合年增长率为4.19%。血液净化设备的需求主要是由于慢性肾臟病（CKD）和终末期肾病（ESRD）患者数量的增加，导致肾病的高血压、糖尿病患者数量迅速增加。由于血液净化设备的采用增加，损害、血液透析技术的进步以及产品批准的增加正在扩大。

血液净化装置市场动态

慢性肾病（CKD）和末期肾病（ESRD）患者数量的增加是血液净化设备市场的主要驱动因素之一。研究表明，慢性病往往影响世界上约 10% 的成年人口。已知糖尿病、高血压、血管疾病和肾丝球肾炎等疾病会导致慢性肾臟疾病。除上述原因外，肾丝球肾炎和间质性肾炎也是低收入国家慢性肾臟病的主要原因。根据这项研究，CKD 往往会影响某些年龄层和性别，但在老年人中更为常见，各种研究表明，全球 64 岁以上人群中 CKD 盛行率为 23%。约为 36%。

除了上述数量外，International Society of Nephrology也宣布，到2022年，全球将有8.5亿人患有某种形式的肾臟疾病。

糖尿病和高血压等慢性肾病危险因子的增加正在推动对血液净化设备的需求。根据International Diabetes Federation（2021）发布的数据，2021年约有5.37亿20岁至79岁的成年人患有糖尿病。

然而，血液净化设备的高成本以及与血液净化程序相关的风险预计将限制预测期内的市场成长。

血液净化设备细分市场分析

按血液净化设备市场的类型细分，便携式血液净化设备类别预计将成为市场上最大的成长领域。原因是便携式血液净化设备具有的优势，例如占用空间较小，并且易于移动设备，尤其是在重症监护病房中。因此，医疗保健专业人员可能会首选它们来治疗患者。

便携式血液净化装置可以让患者在接受透析的同时继续进行日常活动，放鬆或完全消除食物和液体限制以及减轻药物负担，从而改善患者的生活品质。例如，2022年3月12日，Baxter宣布美国FDA核准AK 98血液透析机。这项新技术为透析提供者提供了紧凑、便携且易于使用的系统。该设备具有稳定的底座设计，便于浓缩液和便携式逆渗透膜的储存和运输。随着此类设备的批准，未来对便携式设备的需求预计会增加，因为与固定式血液净化设备相比，它们往往能提供更好的结果。这导致了便携式血液净化设备市场的成长。

北美预计将主导整个血液净化设备市场。

在所有地区中，北美估计在血液净化设备市场中占据最大份额。这一优势是由于肾臟疾病的盛行率不断上升以及患有肥胖和高血压等生活方式相关疾病的患者人数不断增加。此外，广泛的产品开发活动和家用透析机的日益普及预计将进一步推动北美地区的产品需求。除上述因素外，新产品的推出和批准以及美国特定手术成本的广泛覆盖预计将进一步推动北美血液净化设备市场的发展。

根据美国疾病管制与预防中心所引用的数据（2023），估计美国约有 15% 的成年人患有慢性肾臟病。此外，估计显示女性的 CKD 发病率略高于男性。随着时间的推移，慢性肾臟病会进展为肾衰竭并需要透析。因此，患者人数的增加表明肾臟疾病负担的增加，对应于需要透析作为维持生命治疗的潜在患者群体的存在，从而对国内产品需求产生积极影响。

本报告研究和分析了全球血液净化设备市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第1章 血液净化装置报告简介

第2章 血液净化装置概要

  • 调查范围
  • 市场概况
  • 竞争评估

第3章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章 血液净化设备主要因素分析

  • 血液净化设备市场驱动因素
    • 慢性肾病（CKD）和末期肾病（ESRD）患者数量增加
    • 导致肾臟损伤的高血压和糖尿病患者迅速增加
    • 血液透析技术进步
  • 血液净化装置市场限制因素及挑战
    • 血液净化设备成本高
    • 与血液净化程序相关的风险
  • 血液净化装置市场机会
    • 血液净化装置应用于各领域。

第5章 血液净化装置的波特五力分析

第6章 血液净化装置市场布局

  • 按产品类型
    • 血液透析机
    • 血液过滤装置
    • 连续性肾臟替代疗法 (CRRT) 装置
    • 血液灌流装置
    • 血浆置换装置
  • 按类型
    • 固定式
    • 便携的
  • 按最终用户
    • 医院
    • 诊断中心
    • 其他
  • 按地区
    • 北美血液净化装置市场规模（2021-2030）
    • 欧洲血液净化设备市场规模（2021-2030）
    • 亚太地区血液净化设备市场规模（2021-2030）
    • 其他地区血液净化装置市场规模（2021-2030年）

第7章 血液净化装置企业及产品简介

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Fresenius SE and Co. KGaA
  • Baxter International Inc.
  • Infomed SA
  • Jafron Biomedical Co., Ltd.
  • Kaneka Corporation
  • Nikkiso Co, ltd.
  • SWS Medical Group
  • Medtronic, Inc.
  • CytoSorbents Europe GmbH
  • Spectral Medical Inc
  • Haemonetics Corporation
  • Ceus Corporation
  • ExThera Medical Corporation

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第11章 关于 DelveInsight

第12章 免责声明与联络我们

Product Code: DIMDCL0044

Blood Purification Devices Market By Product Type (Hemodialysis Device, Blood Filtration Device, Continuous Renal Replacement Therapy (CRRT) Device, Hemoperfusion Device, and Plasma Exchange Device), Type (Portable And Stationary), Application (Diagnostics and Therapeutics) End-User (Hospitals, Dialysis Centres and Others), and Geography is expected to grow at a steady CAGR Forecast till 2030 owing to an Increase In the number of cases for hypertension and the rise observed in the chronic kidney disease (CKD) and end-stage renal disease patients

The global blood purification devices market was valued at USD 4.90 billion in 2023, growing at a CAGR of 4.19% during the forecast period from 2024 to 2030, to reach USD 6.27 billion by 2030. The demand for blood purification devices is primarily witnessing growth on account of the increase in the number of Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) patients, the surge in the cases of hypertension and diabetes leading to kidney disorders, technological advancements in hemodialysis, increasing product approvals, and increase in adoption of blood purification equipment.

Blood Purification Devices Market Dynamics:

The rising number of patients suffering from Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) is one of the major reasons for driving the Blood Purification Devices market. As per research studies, chronic disease tends to affect about 10% of the world's adult population. Several conditions comprising diabetes, hypertension, vascular disease, and glomerulonephritis are known to cause chronic renal disease. Even in low-income countries, besides the above-known causes, glomerulonephritis and interstitial nephritis are the major cause of most chronic kidney disease cases. According to this research, although CKD tends to affect certain age groups and sexes, it is more prevalent in the case of aged individuals, and various studies have estimated that the worldwide prevalence of CKD is 23-36% in people aged >=64.

In addition to the above data, the International Society of Nephrology stated that, worldwide, 850 million people were living with some form of kidney disease in 2022.

The increasing number of risk factors including diabetes, hypertension, and others associated with causing chronic kidney disease are going to assist in the growing demand for blood purification devices. The data published by International Diabetes Federation 2021 stated that around 537 million adults aged between 20 and 79 years were suffering from diabetes in 2021.

However, the high cost of blood purification equipment and the risks associated with blood purification procedures are expected to limit the market growth over the forecast period.

Blood Purification Devices Market Segment Analysis:

Blood Purification Devices Market by Product Type (Hemodialysis Device, Blood Filtration Device, Continuous Renal Replacement Therapy (CRRT) Device, Hemoperfusion Device, and Plasma Exchange Device), Type (Portable and Stationary), Application (Diagnostics and Therapeutics), End-User (Hospitals, Dialysis Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type segment of the blood purification devices market, the portable blood purification devices category is anticipated to be the largest growing segment in the market. The reason is the advantages that are offered by the portable type of blood purification devices such as less utilization of space and ease related to movement of the devices, specifically in critical care units. Therefore, these are most likely preferred by healthcare professionals for the treatment of patients.

Portable blood purification devices can potentially improve the quality of patient life by allowing them to continue with their daily activities of life while undergoing dialysis as well as by loosening-or removing entirely-dietary and fluid restrictions and reducing pill burden. For instance, on March 12, 2022, Baxter announced the US FDA approval of the AK 98 Hemodialysis Machine. The latest technology provides a compact, portable, and easy-to-use system for dialysis providers. The machine has a stable base design which allows for easy concentrate or portable reverse osmosis storage and transportation of the machine. Due to the approval of such devices, the demand for portable devices is expected to rise in the future as they tend to offer better results in comparison to stationary blood purification devices. This will lead to the growth of the portable blood purification devices market.

North America is expected to dominate the overall Blood Purification Devices Market:

Among all the regions, North America is estimated to account for the largest share of the blood purification devices market. This domination is due to the rising prevalence of kidney disorders, and the rising population of patients suffering from lifestyle disorders such as obesity and hypertension. Moreover, extensive efforts in product developmental activities and the growing popularity of home-based dialysis devices are further expected to drive product demand in the North American region. In addition to the above-stated factors, the new product launches and approvals and the extensive coverage of procedural costs specifically in the United States are expected to further boost the market for blood purification devices in North America.

As per the data cited by the Centers for Disease Control and Prevention (2023), about 15% of adults in the United States (accounting for approximately 37 million people) are estimated to have chronic kidney disease. According to further estimates presented by the source, women are slightly more affected by CKD as compared to men. CKD, over time, progresses to kidney failure thereby necessitating the need for dialysis. Therefore, the growing burden of kidney disorders indicated by the increase in patient population corresponds to the presence of a potential patient population that may require dialysis as a life-supporting therapy, thus positively influencing the product demand in the nation.

Additionally, another key factor that is thought to contribute to the increasing prevalence of kidney disorders is the surge in obesity in the country's population. For instance, as per the data provided by the CDC (2023), in 2017-2018, the obesity prevalence in the country was 42.4%. Obesity has been established as a formidable risk factor for the development of kidney disease. It has been studied that in patients affected by obesity, a compensatory mechanism of hyperfiltration is said to take place to meet the increased metabolic demands due to a gain in body weight. This can massively increase the intraglomerular pressure which may damage the kidney structure and escalate the risk of developing CKD in the long term.

Thus, the interplay of all the previous factors is likely to contribute to the market growth of blood purification devices in the United States as well as the North America region as a whole during the forecast period.

Blood Purification Devices Market Key Players:

Some of the key market players operating in the blood purification devices market include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE and Co. KGaA, Infomed SA, Jafron Biomedical Co., Ltd., Kaneka Corporation, Nikkiso Co, ltd. and SWS Medical Group, CytoSorbents Europe GmbH, Spectral Medical Inc., Haemonetics Corporation, Medtronic, Cerus Corporation, ExThera Medical Corporation and others.

Blood Purification Devices Market Recent Developmental Activities:

In December 2022, Medtronic launched the first neonatal dialysis machine in the US.

In June 2022, the New York-based startup, Qidni Labs, a company pursuing waterless and mobile blood purification systems, announced that they are looking forward to human trials in 2022 following a successful animal study.

In March 2022, Baxter received FDA clearance for its latest, portable dialysis machine designed to connect directly with electronic medical records for patients' prescriptions and treatment data.

Key Takeaways from the Blood Purification Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global blood purification devices market.

Various opportunities available for the other competitor in the blood purification devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for market growth in the coming future?

Target Audience who can be benefited from this Blood Purification Devices Market Report Study

Blood Purification Devices providers

Research organizations and consulting companies

Blood Purification Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders

Various End-users who want to know more about the blood purification devices market and the latest technological developments in the blood purification devices market.

Frequently Asked Questions for Blood Purification Devices Market:

1. What are Blood Purification Devices?

Blood Purification is a procedure that involves the withdrawal of blood from the patient's body into a device or equipment to eliminate the impurities and pump them back into the body. The blood purification devices are similar to that of dialysis equipment. These devices use thin fibers for capturing and removing viruses and help in filtering blood.

2. What is the market for global blood purification devices?

The global blood purification devices market was valued at USD 4.90 billion in 2023, growing at a CAGR of 4.19% during the forecast period from 2024 to 2030, to reach USD 6.27 billion by 2030.

3. What are the drivers for global blood purification devices?

The major drivers driving the demand for global blood purification devices are the increase in the number of chronic kidney disease and end-stage renal disease patients, the increasing number of cases of hypertension and diabetes leading to kidney disorders, technological advancements in hemodialysis, the rise in the number of product approvals by FDA and increase in adoption of blood purification equipment.

4. Who are the key players operating in the global blood purification devices?

Some of the key market players operating in the blood purification devices market include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE and Co. KGaA, Infomed SA, Jafron Biomedical Co., Ltd., Kaneka Corporation, and others.

5. Which region has the highest share in the blood purification devices market?

North America is expected to dominate the overall blood purification devices during the forecast period, 2024 to 2030. This domination is due to the rising prevalence of CKD and ESRD in patients along with the increased awareness regarding blood purification devices and the rapid expansion of healthcare infrastructure.

Table of Contents

1. Blood Purification Devices Report Introduction

2. Blood Purification Devices Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Blood Purification Devices Key Factors Analysis

  • 4.1. Blood Purification Devices Market Drivers
    • 4.1.1. Increase in number of Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) patients
    • 4.1.2. Surge in the cases of hypertension and diabetes leading to kidney disorders
    • 4.1.3. Technological advancements in hemodialysis
  • 4.2. Blood Purification Devices Market Restraints and Challenges
    • 4.2.1. High cost of blood purification devices
    • 4.2.2. Risks associated with the blood purification procedures
  • 4.3. Blood Purification Devices Market Opportunities
    • 4.3.1. Blood Purification Devices have applications in various domains

5. Blood Purification Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Blood Purification Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Hemodialysis Device
    • 6.1.2. Blood Filtration Device
    • 6.1.3. Continuous Renal Replacement Therapy (CRRT) Device
    • 6.1.4. Hemoperfusion Device
    • 6.1.5. Plasma Exchange Device
  • 6.2. By Type
    • 6.2.1. Stationary
    • 6.2.2. Portable
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Diagnostic Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Blood Purification Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.1. France Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Blood Purification Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.1. China Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Blood Purification Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Blood Purification Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Blood Purification Devices Market Size in USD million (2021-2030)

7. Blood Purification Devices Company and Product Profiles

  • 7.1. Asahi Kasei Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. B. Braun Melsungen AG
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Fresenius SE and Co. KGaA
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Baxter International Inc.,
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Infomed SA
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Jafron Biomedical Co., Ltd.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Kaneka Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Nikkiso Co, ltd.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. SWS Medical Group
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Medtronic, Inc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. CytoSorbents Europe GmbH
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Spectral Medical Inc
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Haemonetics Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Ceus Corporation
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. ExThera Medical Corporation
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Blood Purification Devices Market in Global (2021-2030)
  • Table 3: Blood Purification Devices Market in Global by Type (2021-2030)
  • Table 4: Blood Purification Devices Market in Global by Product Type (2021-2030)
  • Table 5: Blood Purification Devices Market in Global by End-User (2021-2030)
  • Table 6: Blood Purification Devices Market in Global by Geography (2021-2030)
  • Table 7: Blood Purification Devices Market in North America (2021-2030)
  • Table 8: Blood Purification Devices Market in the US (2021-2030)
  • Table 9: Blood Purification Devices Market in Canada (2021-2030)
  • Table 10: Blood Purification Devices Market in Mexico (2021-2030)
  • Table 11: Blood Purification Devices Market in Europe (2021-2030)
  • Table 12: Blood Purification Devices Market in France (2021-2030)
  • Table 13: Blood Purification Devices Market in Germany (2021-2030)
  • Table 14: Blood Purification Devices in the United Kingdom (2021-2030)
  • Table 15: Blood Purification Devices Market in Italy (2021-2030)
  • Table 16: Blood Purification Devices Market in Spain (2021-2030)
  • Table 17: Blood Purification Devices Market in Rest of Europe (2021-2030)
  • Table 18: Blood Purification Devices in Asia-Pacific (2021-2030)
  • Table 19: Blood Purification Devices Market in China (2021-2030)
  • Table 20: Blood Purification Devices Market in Japan (2021-2030)
  • Table 21: Blood Purification Devices Market in India (2021-2030)
  • Table 22: Blood Purification Devices Market in Australia (2021-2030)
  • Table 23: Blood Purification Devices Market in South Korea (2021-2030)
  • Table 24: Blood Purification Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Blood Purification Devices Market in the Rest of the World (2021-2030)
  • Table 26: Blood Purification Devices Market in the Middle East (2021-2030)
  • Table 27: Blood Purification Devices Market in Africa (2021-2030)
  • Table 28: Blood Purification Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Blood Purification Devices Market in Global (2021-2030)
  • Figure 3: Blood Purification Devices Market in Global by Type (2021-2030)
  • Figure 4: Blood Purification Devices Market in Global by Product Type (2021-2030)
  • Figure 5: Blood Purification Devices Market in Global by End-User (2021-2030)
  • Figure 6: Blood Purification Devices Market in Global by Geography (2021-2030)
  • Figure 7: Blood Purification Devices Market in North America (2021-2030)
  • Figure 8: Blood Purification Devices Market in the US (2021-2030)
  • Figure 9: Blood Purification Devices Market in Canada (2021-2030)
  • Figure 10: Blood Purification Devices Market in Mexico (2021-2030)
  • Figure 11: Blood Purification Devices Market in Europe (2021-2030)
  • Figure 12: Blood Purification Devices Market in France (2021-2030)
  • Figure 13: Blood Purification Devices Market in Germany (2021-2030)
  • Figure 14: Blood Purification Devices Market in the United Kingdom (2021-2030)
  • Figure 15: Blood Purification Devices Market in Italy (2021-2030)
  • Figure 16: Blood Purification Devices Market in Spain (2021-2030)
  • Figure 17: Blood Purification Devices Market in Rest of Europe (2021-2030)
  • Figure 18: Blood Purification Devices Market in Asia-Pacific (2021-2030)
  • Figure 19: Blood Purification Devices Market in China (2021-2030)
  • Figure 20: Blood Purification Devices Market in Japan (2021-2030)
  • Figure 21: Blood Purification Devices Market in India (2021-2030)
  • Figure 22: Blood Purification Devices Market in Australia (2021-2030)
  • Figure 23: Blood Purification Devices Market in South Korea (2021-2030)
  • Figure 24: Blood Purification Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Blood Purification Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Blood Purification Devices Market in the Middle East (2021-2030)
  • Figure 27: Blood Purification Devices Market in Africa (2021-2030)
  • Figure 28: Blood Purification Devices Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 32: PORTER'S Five Force Analysis